Advertisement

Topics

FDA approves first oral medication for treatment of adults with Fabry disease

17:17 EDT 10 Aug 2018 | News-Medical.net

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

Original Article: FDA approves first oral medication for treatment of adults with Fabry disease

NEXT ARTICLE

More From BioPortfolio on "FDA approves first oral medication for treatment of adults with Fabry disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...